Chikungunya Fever Cases Identified in the Veterans Health Administration System, 2014

por Perti, Tara, Lucero-Obusan, Cynthia A., Schirmer, Patricia L., Winters, Mark A., Holodniy, Mark
Publicado 2016

Development of Elvitegravir Resistance and Linkage of Integrase Inhibitor Mutations with Protease and Reverse Transcriptase Resistance Mutations

por Winters, Mark A., Lloyd, Robert M., Shafer, Robert W., Kozal, Michael J., Miller, Michael D., Holodniy, Mark
Publicado 2012

Detection of HIV-1 in Saliva: Implications for Case-Identification, Clinical Monitoring and Surveillance for Drug Resistance()

por Balamane, Maya, Winters, Mark A, Dalai, Sudeb C, Freeman, Alexandra H, Traves, Mark W, Israelski, Dennis M, Katzenstein, David A, Klausner, Jeffrey D
Publicado 2010

Immune Biomarker Differences and Changes Comparing HCV Mono-Infected, HIV/HCV Co-Infected, and HCV Spontaneously Cleared Patients

por Kushner, Lauren E., Wendelboe, Aaron M., Lazzeroni, Laura C., Chary, Aarthi, Winters, Mark A., Osinusi, Anu, Kottilil, Shyam, Polis, Michael A., Holodniy, Mark
Publicado 2013

Zika virus infection in the Veterans Health Administration (VHA), 2015-2016

por Schirmer, Patricia L., Wendelboe, Aaron, Lucero-Obusan, Cynthia A., Ryono, Russell A., Winters, Mark A., Oda, Gina, Martinez, Mirsonia, Saavedra, Sonia, Holodniy, Mark
Publicado 2018

HIV-1 Protease, Reverse Transcriptase, and Integrase Variation

por Rhee, Soo-Yon, Sankaran, Kris, Varghese, Vici, Winters, Mark A., Hurt, Christopher B., Eron, Joseph J., Parkin, Neil, Holmes, Susan P., Holodniy, Mark, Shafer, Robert W.
Publicado 2016

Pharmacokinetics and pharmacodynamics modeling of lonafarnib in patients with chronic hepatitis delta virus infection

por Canini, Laetitia, Koh, Christopher, Cotler, Scott J., Uprichard, Susan L., Winters, Mark A., Han, Ma Ai Thanda, Kleiner, David E., Idilman, Ramazan, Yurdaydin, Cihan, Glenn, Jeffrey S., Heller, Theo, Dahari, Harel
Publicado 2017

Safety and Efficacy of Autologous CD34+ Hematopoietic Progenitor Cells Transduced with an Anti-Tat Ribozyme in a Multi-Center, Randomized, Placebo-Controlled, Phase II Gene Therapy...

por Mitsuyasu, Ronald T, Merigan, Thomas C, Carr, Andrew, Zack, Jerome A, Winters, Mark A, Workman, Cassy, Bloch, Mark, Lalezari, Jacob, Becker, Stephen, Thornton, Lorna, Akil, Bisher, Khanlou, Homayoon, Finlayson, Robert, McFarlane, Robert, Smith, Don E, Garsia, Roger, Ma, David, Law, Matthew, Murray, John M., von Kalle, Christof, Ely, Julie A, Patino, Sharon M, Knop, Alison E, Wong, Philip, Todd, Alison V, Haughton, Margaret, Fuery, Caroline, Macpherson, Janet L, Symonds, Geoff P, Evans, Louise A, Pond, Susan M, Cooper, David A
Publicado 2009